Published in Nat Rev Clin Oncol on August 14, 2012
Extending the National Health Service (NHS) Breast Screening Age Range (AgeX) | NCT01081288
Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol (2014) 3.04
Earlier diagnosis of breast cancer: focusing on symptomatic women. Nat Rev Clin Oncol (2013) 1.05
Framing overdiagnosis in breast screening: a qualitative study with Australian experts. BMC Cancer (2015) 0.81
Using an informed consent in mammography screening: a randomized trial. Cancer Med (2015) 0.77
Mammography screening and women with symptomatic breast cancer. Nat Rev Clin Oncol (2013) 0.75
Earlier diagnosis of breast cancer outside of a screening programme. Nat Rev Clin Oncol (2013) 0.75
Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2009) 21.55
Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70
Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet (2002) 13.16
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96
Overdiagnosis in cancer. J Natl Cancer Inst (2010) 10.31
Rethinking screening for breast cancer and prostate cancer. JAMA (2009) 7.83
Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med (2012) 7.78
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet (1987) 6.91
Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst (2000) 4.98
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med (2009) 4.60
Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol (2005) 4.35
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med (2011) 4.28
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Lessons from the mammography wars. N Engl J Med (2010) 3.68
Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol (2007) 3.49
Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst (2010) 3.39
Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med (2008) 2.83
Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst (2010) 2.80
Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death. AJR Am J Roentgenol (2012) 2.59
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med (2007) 1.93
Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev (2011) 1.77
Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening. J Clin Oncol (2009) 1.71
Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat (2011) 1.55
Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol (2011) 1.53
Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Couns (2010) 1.48
How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer (2009) 1.40
Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat (2011) 1.39
Overdiagnosis in breast cancer screening: time to tackle an underappreciated harm. Ann Intern Med (2012) 1.32
Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits. Br J Cancer (2005) 1.26
Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat (2011) 1.17
Solving the overdiagnosis dilemma. J Natl Cancer Inst (2010) 1.03
The evidence base for breast cancer screening. Prev Med (2011) 1.02
The trouble with screening. Lancet (2009) 1.01
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res Treat (2011) 1.00
Breast cancer screening for women ages 50 to 69 years a systematic review of observational evidence. Prev Med (2011) 0.97
Ductal carcinoma in situ of the breast: impact of pathology on therapeutic decisions. Am J Surg Pathol (2003) 0.93
Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project. Clin Radiol (2010) 0.89
Breast density influences tumor subtypes and tumor aggressiveness. J Natl Cancer Inst (2011) 0.79
Effect of population-based screening on breast cancer mortality. Lancet (2012) 0.78
Proportional incidence and radiological review of large (T2+) breast cancers as surrogate indicators of screening programme performance. Eur Radiol (2011) 0.77
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med (2014) 3.78
Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol (2007) 3.49
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology (2012) 3.36
The UCSC Cancer Genomics Browser. Nat Methods (2009) 3.08
Model of outcomes of screening mammography: information to support informed choices. BMJ (2005) 2.86
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2012) 2.62
Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol (2013) 2.52
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol (2014) 2.38
The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study. Plast Reconstr Surg (2012) 2.37
Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ (2013) 2.25
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users. Cancer Epidemiol Biomarkers Prev (2008) 2.12
Breast cancer growth prevention by statins. Cancer Res (2006) 2.09
Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapy. Radiology (2012) 2.07
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol (2005) 2.06
A novel case-control design to estimate the extent of over-diagnosis of breast cancer due to organised population-based mammography screening. Int J Cancer (2014) 2.00
Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol (2002) 2.00
Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma. Ann Surg Oncol (2002) 1.99
The Society of Surgical Oncology-American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast Cancer: Perspectives for Pathologists. Arch Pathol Lab Med (2014) 1.98
Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A (2011) 1.97
Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis. Med J Aust (2012) 1.95
Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med (2007) 1.93
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition. J Exp Med (2012) 1.85
Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol (2008) 1.71
Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg (2010) 1.70
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol (2005) 1.69
Beyond mammography: new frontiers in breast cancer screening. Am J Med (2013) 1.61
Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology (2011) 1.59
Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol (2009) 1.58
Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol (2014) 1.50
Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Couns (2010) 1.48
EUSOMA criteria for performing pre-operative MRI staging in candidates for breast conserving surgery: hype or helpful? Breast (2012) 1.48
Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial. J Am Coll Surg (2009) 1.46
Life after breast cancer. Aust Fam Physician (2006) 1.43
Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Breast J (2006) 1.43
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat (2010) 1.42
Would the real breast cancer please stand up? A global perspective of breast cancer. Breast (2008) 1.42
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res (2008) 1.42
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol (2008) 1.42
Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer (2004) 1.40
Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg (2009) 1.39
A first evaluation of breast radiological density assessment by QUANTRA software as compared to visual classification. Breast (2012) 1.37
Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn (2011) 1.37
Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians. J Clin Oncol (2002) 1.37
Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts. AJR Am J Roentgenol (2007) 1.36
Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up. Eur J Cancer (2011) 1.33
Medical tests: women's reported and preferred decision-making roles and preferences for information on benefits, side-effects and false results. Health Expect (2002) 1.30
Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging. Breast Cancer Res Treat (2006) 1.29
Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer (2008) 1.28
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol (2014) 1.28
Compositional breast imaging using a dual-energy mammography protocol. Med Phys (2010) 1.26
Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat (2006) 1.22
Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst (2013) 1.21
Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat (2011) 1.17
Expanding the reach of decision and communication aids in a breast care center: a quality improvement study. Patient Educ Couns (2010) 1.14
Optimizing the total skin-sparing mastectomy. Arch Surg (2008) 1.14
Benefits, harms and costs of screening mammography in women 70 years and over: a systematic review. Med J Aust (2002) 1.12
Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias. Breast Cancer Res Treat (2008) 1.11
Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. Radiology (2008) 1.10
Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol (2013) 1.10
Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol (2003) 1.10
Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol (2007) 1.06
Digital breast tomosynthesis might not be the optimal modality for detecting microcalcification. Radiology (2015) 1.06
Total skin-sparing mastectomy: a systematic review of oncologic outcomes and postoperative complications. Ann Plast Surg (2013) 1.05
When informed, all women do not prefer breast conservation. J Clin Oncol (2008) 1.05
Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Breast Cancer Res Treat (2013) 1.05
Consumer information materials for diagnostic breast tests: women's views on information and their understanding of test results. Health Expect (2003) 1.04
Comparative estimation of percentage breast tissue density for digital mammography, digital breast tomosynthesis, and magnetic resonance imaging. Breast Cancer Res Treat (2013) 1.03
The evidence base for breast cancer screening. Prev Med (2011) 1.02
Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium. Cancer Res (2003) 1.00
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res Treat (2011) 1.00
Full field digital mammography and breast density: comparison of calibrated and noncalibrated measurements. Acad Radiol (2011) 1.00
Prospective study of breast tomosynthesis as a triage to assessment in screening. Breast Cancer Res Treat (2012) 1.00
Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ. BMC Cancer (2009) 0.99
A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes. J Clin Oncol (2006) 0.99
Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol (2013) 0.99
Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ. Am J Surg (2006) 0.99
A comparison of RNA amplification techniques at sub-nanogram input concentration. BMC Genomics (2009) 0.99
Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease. Arch Surg (2005) 0.98
Increasing the time to expander-implant exchange after postmastectomy radiation therapy reduces expander-implant failure. Plast Reconstr Surg (2012) 0.97
Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol (2012) 0.97
Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis. BMC Cancer (2009) 0.97
Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw (2006) 0.97
Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat (2013) 0.96
Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer. J Clin Oncol (2007) 0.96
Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers. Mol Cell Biol (2002) 0.95
Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience. Cancer (2010) 0.95
Does computer-aided detection (CAD) contribute to the performance of digital mammography in a self-referred population? Breast Cancer Res Treat (2007) 0.95
Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. In Vitro Cell Dev Biol Anim (2002) 0.94
Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes. Ann Surg Oncol (2014) 0.93
Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat (2005) 0.93
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer. Breast Cancer Res Treat (2012) 0.92
Immediate implant-based breast reconstruction following total skin-sparing mastectomy: defining the risk of preoperative and postoperative radiation therapy for surgical outcomes. Plast Reconstr Surg (2014) 0.91
Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat (2011) 0.91
Improving the quality of decision making in breast cancer: consultation planning template and consultation recording template. Oncol Nurs Forum (2003) 0.91
Application of screening principles to the reconstructed breast. J Clin Oncol (2009) 0.90
Accuracy of mammography, digital breast tomosynthesis, ultrasound and MR imaging in preoperative assessment of breast cancer. Anticancer Res (2014) 0.89